Page last updated: 2024-12-05

azetidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Azetidine is a four-membered cyclic amine. It is a highly strained molecule due to the small ring size, making it highly reactive. Azetidine derivatives are found in natural products and have potential applications in medicinal chemistry. They have been studied for their biological activities, including antibacterial, antifungal, and anticancer properties. Their strained nature also makes them useful in organic synthesis as building blocks for more complex molecules. Azetidines can be synthesized through various methods, including ring-closing metathesis, cycloaddition reactions, and ring-opening reactions of aziridines. '

Cross-References

ID SourceID
PubMed CID10422
CHEMBL ID2171713
CHEBI ID30968
MeSH IDM0220354

Synonyms (37)

Synonym
BB 0254753
azacyclobutane
CHEBI:30968 ,
trimethylenimine
trimethylene imine
1,3-propylenimine
azetidine
inchi=1/c3h7n/c1-2-4-3-1/h4h,1-3h
503-29-7
azetidine, 98%
53860-05-2
AKOS000121515
azetidin
CHEMBL2171713
A828069
trimethyleneimine
CM42900000
acetidine
niosh/cm4290000
azetidine, l-
ai3-61395
einecs 207-963-8
unii-37s883xdwr
37s883xdwr ,
FT-0649642
GC10189
1,3-propylenimine;azacyclobutane;azetidine;trimethylene imine
AM20080889
DTXSID8060117
W-105973
azete, tetrahydro-
mfcd00005165
BCP22506
Q425376
EN300-21102
PS-11989
SB52174

Research Excerpts

Overview

Azetidine is a four-membered polar heterocycle including a basic secondary amine. It is characterized by its high ring-strain energy, strong molecular rigidity and satisfactory stability.

ExcerptReferenceRelevance
"Azetidine is a four-membered polar heterocycle including a basic secondary amine, and is characterized by its high ring-strain energy, strong molecular rigidity and satisfactory stability. "( Biosyntheses of azetidine-containing natural products.
Bian, X; Gao, F; Pang, L; Yao, D; Zhang, Y; Zhong, G, 2023
)
2.7

Bioavailability

ExcerptReferenceRelevance
"An orally active carbapenem L-084, which exhibits high bioavailability in humans, has a 1-(1,3-thiazolin-2-yl)azetidin-3-ylthio moiety at the C-2 position of the 1beta-methylcarbapenem skeleton."( A practical and facile synthesis of azetidine derivatives for oral carbapenem, L-084.
Isoda, T; Kumagai, T; Nagao, Y; Tamai, S; Yamamura, I, 2006
)
0.61
" Although it holds promise to be a first-in-class Env-targeted entry inhibitor for the clinic, issues with bioavailability relegate its use to salvage therapies only."( Composition and Orientation of the Core Region of Novel HIV-1 Entry Inhibitors Influences Metabolic Stability.
Cocklin, S; Karadsheh, R; Meuser, ME, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
saturated organic heteromonocyclic parent
azetidines
azacycloalkane
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID781327pKa (acid-base dissociation constant) as determined by Morgenthaler ref: ChemMedChem 20072014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
AID1419135Covalent reactivity with N-alpha-acetyl-L-lysine assessed as half life2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors.
AID701844Dissociation constant, pKa of the compound2012Journal of medicinal chemistry, Jul-12, Volume: 55, Issue:13
Mitigating heterocycle metabolism in drug discovery.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (120)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.67)18.7374
1990's14 (11.67)18.2507
2000's33 (27.50)29.6817
2010's57 (47.50)24.3611
2020's14 (11.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.85 (24.57)
Research Supply Index4.80 (2.92)
Research Growth Index5.44 (4.65)
Search Engine Demand Index80.05 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other115 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]